Bufu Tang

2.8k total citations · 2 hit papers
85 papers, 1.8k citations indexed

About

Bufu Tang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Bufu Tang has authored 85 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 27 papers in Pulmonary and Respiratory Medicine and 22 papers in Cancer Research. Recurrent topics in Bufu Tang's work include Ferroptosis and cancer prognosis (26 papers), RNA modifications and cancer (17 papers) and Cancer Immunotherapy and Biomarkers (13 papers). Bufu Tang is often cited by papers focused on Ferroptosis and cancer prognosis (26 papers), RNA modifications and cancer (17 papers) and Cancer Immunotherapy and Biomarkers (13 papers). Bufu Tang collaborates with scholars based in China, United States and Hong Kong. Bufu Tang's co-authors include Jiansong Ji, Jinyu Zhu, Qiaoyou Weng, Shiji Fang, Zhongwei Zhao, Liyun Zheng, Chenying Lu, Min Xu, Minjiang Chen and Yang Yang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Bufu Tang

72 papers receiving 1.8k citations

Hit Papers

Targeted xCT‐mediated Ferroptosis and Protumoral Polariza... 2022 2026 2023 2024 2022 2024 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bufu Tang China 23 1.1k 727 699 321 291 85 1.8k
Shidai Jin China 20 1.2k 1.1× 933 1.3× 779 1.1× 328 1.0× 99 0.3× 42 1.7k
Haoming Lin China 16 1.1k 1.0× 784 1.1× 513 0.7× 237 0.7× 200 0.7× 47 1.8k
Dan He China 19 1.3k 1.2× 941 1.3× 1.1k 1.6× 397 1.2× 203 0.7× 54 2.3k
Chuangye Han China 24 790 0.7× 644 0.9× 407 0.6× 318 1.0× 116 0.4× 89 1.5k
Ximing Xu China 24 896 0.8× 599 0.8× 324 0.5× 527 1.6× 198 0.7× 101 1.6k
Daiha Shin South Korea 19 1.4k 1.3× 1.1k 1.5× 1.3k 1.9× 326 1.0× 98 0.3× 31 2.3k
Litong Nie United States 16 1.2k 1.1× 634 0.9× 812 1.2× 320 1.0× 223 0.8× 31 1.9k
Xinxin Zhang China 18 684 0.6× 318 0.4× 436 0.6× 517 1.6× 229 0.8× 76 1.5k
Jiancheng Zhou China 25 1.3k 1.1× 546 0.8× 463 0.7× 880 2.7× 195 0.7× 48 2.1k

Countries citing papers authored by Bufu Tang

Since Specialization
Citations

This map shows the geographic impact of Bufu Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bufu Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bufu Tang more than expected).

Fields of papers citing papers by Bufu Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bufu Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bufu Tang. The network helps show where Bufu Tang may publish in the future.

Co-authorship network of co-authors of Bufu Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Bufu Tang. A scholar is included among the top collaborators of Bufu Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bufu Tang. Bufu Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheng, Quan, et al.. (2026). Tumor Immunotherapy and Microbiome: From Bench‐to‐Bedside Applications. MedComm. 7(2). e70454–e70454.
2.
Lin, Anqi, Aimin Jiang, Li Chen, et al.. (2025). Large language models in clinical trials: applications, technical advances, and future directions. BMC Medicine. 23(1). 563–563. 1 indexed citations
3.
Tang, Bufu, Yuan Cao, Jia‐Su Li, et al.. (2025). Whole microbiota transplantation restores gut homeostasis throughout the gastrointestinal tract. iMeta. 4(6). e70091–e70091.
4.
Zhang, Baohui, Bufu Tang, Linlin Chen, et al.. (2025). Oncogenic β-catenin stimulation of cofilin 1-mediated macropinocytosis is druggable for cancer. Theranostics. 15(9). 4176–4187.
5.
Jiang, Aimin, Weiming Mou, Dongqiang Zeng, et al.. (2025). Temporal evolution of large language models (LLMs) in oncology. Journal of Translational Medicine. 23(1). 1219–1219.
6.
Tang, Bufu, Wen Zhang, Yongjie Zhou, et al.. (2025). Sequential HAIC-TACE combined with targeted and immunotherapy in hepatocellular carcinoma: a quality improvement study. International Journal of Surgery. 111(10). 6942–6960.
7.
Gao, Zhifei, Aimin Jiang, Zizhuo Li, et al.. (2025). Heterogeneity of Intratumoral Microbiota Within the Tumor Microenvironment and Relationship to Tumor Development. SHILAP Revista de lepidopterología. 1(1). 32–61. 10 indexed citations
8.
Jiang, Tong, Aimin Jiang, Qi Chang, et al.. (2025). Performance analysis of large language models in multi-disease detection from chest computed tomography reports: a comparative study. International Journal of Surgery. 111(8). 5071–5087. 1 indexed citations
9.
Chen, Li, Anqi Lin, Bufu Tang, et al.. (2025). The Future of Cancer Therapy: Nanomaterials and Tumor Microenvironment. 1(1). 3 indexed citations
10.
Wang, Siwei, Weifeng Hong, Yan Huang, et al.. (2025). Targeting MORF4L1-mediated DNA repair potentiates RT-induced antitumor immunity via cGAS-STING activation in hepatocellular carcinoma. Cellular and Molecular Immunology. 22(12). 1549–1566.
12.
Huang, Li‐Hua, Cangang Zhang, Aimin Jiang, et al.. (2025). T-cell Senescence in the Tumor Microenvironment. Cancer Immunology Research. 13(5). 618–632. 7 indexed citations
13.
Lin, Anqi, Aimin Jiang, Kexin Li, et al.. (2025). Computational approaches to druggable site identification: Current status and future perspective. Acta Pharmaceutica Sinica B. 16(1). 62–92.
14.
Guo, Dandan, Songhua Cai, Wangting Xu, et al.. (2025). Ferroptosis in Pulmonary Disease and Lung Cancer: Molecular Mechanisms, Crosstalk Regulation, and Therapeutic Strategies. MedComm. 6(3). e70116–e70116. 14 indexed citations
15.
Shen, Junyi, Rong Hu, Anqi Lin, et al.. (2024). Characterization of second primary malignancies post CAR T-cell therapy: real-world insights from the two global pharmacovigilance databases of FAERS and VigiBase. EClinicalMedicine. 73. 102684–102684. 30 indexed citations
16.
Zhang, Chun‐Dong, Quanquan Sun, Qianping Chen, et al.. (2023). Unraveling Colorectal Cancer and Pan-cancer Immune Heterogeneity and Synthetic Therapy Response Using Cuproptosis and Hypoxia Regulators by Multi-omic Analysis and Experimental Validation. International Journal of Biological Sciences. 19(11). 3526–3543. 8 indexed citations
18.
Tang, Bufu, Jinyu Zhu, Yajie Wang, et al.. (2022). Targeted xCT‐mediated Ferroptosis and Protumoral Polarization of Macrophages Is Effective against HCC and Enhances the Efficacy of the Anti‐PD‐1/L1 Response. Advanced Science. 10(2). e2203973–e2203973. 145 indexed citations breakdown →
19.
Zhu, Jinyu, Bufu Tang, Yang Gao, et al.. (2021). Predictive Models for HCC Prognosis, Recurrence Risk, and Immune Infiltration Based on Two Exosomal Genes: MYL6B and THOC2. Journal of Inflammation Research. Volume 14. 4089–4109. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026